ישראל -
עברית -
Ministry of Health
אפוקוול 3.6 מג וטרינרי
zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 3.6 mg
ישראל -
עברית -
Ministry of Health
אפוקוול 5.4 מג וטרינרי
zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 5.4 mg
ישראל -
עברית -
Ministry of Health
אפוקוול 5.4 מג וטרינרי
zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 5.4 mg
ישראל -
עברית -
Ministry of Health
אפוקוול 16 מג וטרינרי
zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 16 mg
ישראל -
עברית -
Ministry of Health
צטרימיד שמפו ויטאמד
vitamed pharmaceutical industries ltd - cetrimide - שמפו - cetrimide 10 % - cetrimide - cetrimide - for the treatment of dandruff.
ישראל -
עברית -
Ministry of Health
אלמקס ג'ל
salomon,levin & elstein ltd - amine fluoride mixture 3.319 g / 100 g; sodium fluoride 2.21 g / 100 g - gel - sodium fluoride - routine prophylaxis against caries, individual and collective. cases with a high tendency for caries. treatment of sensitive dental necks.
ישראל -
עברית -
Ministry of Health
טינדן ג'ל
trima israel pharmaceutical products maabarot ltd - dimetindene maleate - ג'ל - dimetindene maleate 0.1 %w/w - dimetindene
ישראל -
עברית -
Ministry of Health
קסמיאול
dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - ג'ל - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - betamethasone - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.
ישראל -
עברית -
Ministry of Health
ארומזין
pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.